Cerebral malaria: Pinpointing a potential therapeutic target

January 16, 2013
Dendritic cells from human blood are integral parts of the immune system. Credit: David Scharf/Science Faction/Corbis

An excessive response of the immune system to malarial infection can lead to serious complications, such as cerebral malaria. While the mechanism causing the onset of cerebral malaria is unclear, immunologists think that contributing factors include cells of the immune system and the inflammation that they cause. Laurent Renia and co-workers at the A*STAR Singapore Immunology Network and collaborators from Nanyang Technological University, Singapore, have now singled out one subtype of immune cells that is key to the onset of this often fatal disease.

The researchers used an established of the disease, called experimental (ECM). Accumulation of CD8+ T cells, that destroy infected or damaged cells, is one known contributing factor in this model. Dendritic cells (see image), another type of immune cell, are important in activating certain types of T cells and are also known to be involved in experimental cerebral malaria.

"Dendritic cells are essential for the development of the in particular T cells," explains Renia. "These cells express different markers and are present in many tissues like the spleen. It was previously shown that splenic dendritic cells are important for ECM to develop."

In the earlier work, dendritic cells were modified so that they could be selectively destroyed. A marker that all dendritic cells express, called CD11c, was targeted with a receptor, allowing them to be killed using this toxin. The targeted destruction of dendritic cells prevented experimental cerebral malaria. However, this method did not discriminate between the several subtypes of dendritic cells that express CD11c, so the exact dendritic cell type responsible remained elusive.

Renia and his co-workers used a similar approach in this study, but targeted a marker called Clec9A with the toxin receptor. Clec9A is expressed by one subtype of dendritic cells only. The subtype, called CD11chighCD8+, is a candidate in experimental cerebral malaria because its cells are involved in activating CD8+ T cells.

Destroying the CD11chighCD8+ cells provided mice with complete protection from experimental cerebral malaria. Renia and co-workers also showed that without these cells, fewer CD8+ T cells were activated in the spleen and fewer were found in the brain. "Our findings show that these are essential to CD8+ T cell development and thus to experimental cerebral malaria," says Renia.

Although this work was done in an artificial model of the disease in mice, Renia notes that it provides a starting point in overcoming the disease in people.

Explore further: Skin sentry cells promote distinct immune responses

More information: Piva, L., et al. Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. The Journal of Immunology 189, 1128–1132 (2012). www.jimmunol.org/cgi/doi/10.4049/jimmunol.1201171

Related Stories

Skin sentry cells promote distinct immune responses

July 21, 2011

A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same ...

How excess alcohol depresses immune function

August 16, 2011

Alcoholism suppresses the immune system, resulting in a high risk of serious, and even life-threatening infections. A new study shows that this effect stems largely from alcohol’s toxicity to immune system cells called ...

Manipulating the immune system to develop 'next-gen' vaccines

April 5, 2012

The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by 'tricking' cells into launching an immune response, leading to next-generation vaccines that are more specific, ...

Recommended for you

Snapshot turns T cell immunology on its head

October 6, 2015

Challenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excellence in advanced Molecular imaging has shown the ...

Four gut bacteria decrease asthma risk in infants

September 30, 2015

New research by scientists at UBC and BC Children's Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age. More than 300 families from across Canada ...

Flu infection reveals many paths to immune response

September 28, 2015

A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological ...

Immune cells may help fight against obesity

September 15, 2015

While a healthy lifestyle and "good genes" are known to help prevent obesity, new research published on September 15 in Immunity indicates that certain aspects of the immune system may also play an important role. In the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.